Entresto (sacubitril/valsartan) is a combination medication used mainly for chronic heart‑failure with reduced ejection fraction. It works by blocking angiotensin receptors (valsartan) and inhibiting neprilysin (sacubitril), which together help lower blood pressure, reduce fluid buildup, and improve heart function.
Why you might notice weight loss
| Potential Factor |
How it can lead to weight loss |
| Reduced fluid retention |
Heart‑failure medications often relieve edema. The weight you lose might be mostly water, not fat. |
| Lower appetite or nausea |
Some people experience mild GI side‑effects that reduce food intake. |
| Improved energy expenditure |
As heart function improves, daily activity levels may rise, burning more calories. |
| Medication‑related changes |
Sacubitril can increase levels of natriuretic peptides that influence metabolism, though this effect is modest. |
In most cases, a 30‑lb loss over a year is a gradual and manageable change, but it’s important to ensure it’s healthy and not due to other factors.
Things to keep an eye on
-
Blood pressure and potassium
Entresto can lower blood pressure and raise potassium. A sudden drop in weight could coincide with hypotension or electrolyte shifts. Check with your clinician if you feel dizzy or weak.
-
Heart‑failure symptoms
If you’re losing weight but also feel short of breath, swollen ankles, or have sudden fatigue, report it promptly. A decline in fluid overload can be a good sign, but any new symptoms warrant a check‑up.
-
Nutritional status
Losing 30 lbs in a year averages ~0.5 lb/week, which is within a safe weight‑loss range. Still, ensure you’re getting balanced nutrition—especially protein, which is important for heart health and muscle maintenance.
-
Exercise
Regular, moderate aerobic activity and strength training can help maintain muscle mass while you lose excess weight. Ask your cardiologist or a physical‑rehab specialist for a tailored plan.
When to talk to your provider
| Scenario |
Why it matters |
| Weight loss > 5% of baseline in 6 weeks |
Could signal fluid shifts or other side‑effects. |
| New or worsening fatigue, dizziness, palpitations |
Might indicate hypotension or electrolyte imbalance. |
| Changes in appetite or GI symptoms |
Could affect nutrition and overall health. |
| Unexplained swelling or edema |
May point to heart‑failure status changes. |
If any of these happen—or if you’re simply curious about the changes—bring the conversation up during your next visit. Your provider can review your labs, adjust medication if needed, and ensure the weight loss is safe and aligned with your heart‑failure goals.
Bottom line
A 30‑lb weight loss over a year after starting Entresto is generally a gradual and manageable change. It may reflect reduced fluid retention, modest appetite changes, or improved energy use. Keep track of how you feel, monitor basic vitals, and stay in touch with your cardiology team. If anything feels off, don’t hesitate to reach out—early adjustments can keep you healthier and safer.